{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:49:26Z","timestamp":1783478966363,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.metabol.2010.10.002","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T04:20:24Z","timestamp":1289967624000},"page":"1045-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus\u2013infected lipoatrophic men treated with pioglitazone: a pilot study"],"prefix":"10.1016","volume":"60","author":[{"given":"Faidon","family":"Magkos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Seok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Doweiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolf W.","family":"Karchmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2010.10.002_bb0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2010.10.002_bb0010","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jc.2002-021704","article-title":"Human immunodeficiency virus\/highly active antiretroviral therapy\u2013associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies","volume":"88","author":"Leow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2010.10.002_bb0015","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","article-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women","volume":"40","author":"Jacobson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.metabol.2010.10.002_bb0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1\u2013related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.metabol.2010.10.002_bb0025","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/00002030-200303280-00022","article-title":"Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy","volume":"17","author":"Calmy","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2010.10.002_bb0030","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/427697","article-title":"Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 \u00d7 2 factorial, randomized, double-blinded, placebo-controlled trial","volume":"40","author":"Gavrila","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.metabol.2010.10.002_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/135965350801300107","article-title":"Effect of pioglitazone on HIV-1\u2013related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113)","volume":"13","author":"Slama","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.metabol.2010.10.002_bb0040","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/jc.2005-1545","article-title":"Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy","volume":"91","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2010.10.002_bb0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia","volume":"94","author":"Mulligan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2010.10.002_bb0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00125-009-1547-9","article-title":"An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics","volume":"53","author":"Tura","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2010.10.002_bb0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2010.10.002_bb0060","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.2337\/diacare.27.9.2204","article-title":"Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity","volume":"27","author":"Tripathy","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2010.10.002_bb0065","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1152\/jappl.1988.65.6.2395","article-title":"Plasma glucose and insulin responses to oral and intravenous glucose in cold-exposed humans","volume":"65","author":"Vallerand","year":"1988","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.metabol.2010.10.002_bb0070","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2337\/diabetes.48.5.958","article-title":"Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans","volume":"48","author":"Capaldo","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2010.10.002_bb0075","doi-asserted-by":"crossref","first-page":"E47","DOI":"10.1152\/ajpendo.00236.2005","article-title":"Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia","volume":"290","author":"Reeds","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049510003495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049510003495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:52:48Z","timestamp":1758426768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049510003495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0026049510003495"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2010.10.002","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus\u2013infected lipoatrophic men treated with pioglitazone: a pilot study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2010.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}